Amneal Pharmaceuticals has submitted another NDA for its DHE prefilled syringe autoinjector to treat tough-to-treat headaches ...

Amneal Resubmits DHE Autoinjector New Drug Application and Receives U.S. FDA Approval of Exenatide, its First Generic Injectable GLP-1 Agonist ...

A bumetanide nasal spray in development for heart failure was well-tolerated and showed reliable rates of absorption compared ...

This rainy weather plus the incoming holiday stress can trigger migraines. But there’s a brand new medicine available for ...

A nasal spray would be a workaround for drug resistance seen with oral diuretics, with the potential to reduce hospital ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Tonix Pharmaceuticals Holding Corp. with financial support from Tonix. The two organizations ...

This post was written and published as a collaboration between the in-house editorial team at Benzinga and Corp. with ...

Commercial launch of neffy® (epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by FDA; PDUFA target date set for March 6, 2025Exclusive ...

Commercial launch of neffy®(epinephrine nasal spray) underway in the United StatesSupplemental NDA for neffy®1mg dose granted priority review by ...

We have closely followed developments with neffy since ARS Pharma first demonstrated that safe, low-dose, injection-like delivery of epinephrine could be achieved through a nasal spray,” said ...

Amanda Gardner is a freelance health reporter whose stories have appeared in cnn.com, health.com, cnn.com, WebMD, HealthDay, Self Magazine, the New York ... Post-nasal drip treatments include ...

This secondary headache happens because of an allergic reaction with much of the pain focusing around the sinus area. Taking anti-histamines (even if you don't have any symptoms) will help keep these ...